Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Sell
Price to Earnings Rating
Neutral
Analyst Rating
Buy
Simple Moving Average
Strong Buy
Exponential Moving Average
Strong Buy
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
Protagonist Therapeutics, Inc (PTGX)
Pharmaceutical Preparations
https://www.protagonist-inc.com
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
7707 GATEWAY BLVD., SUITE 140
NEWARK, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
08/11/2016
Market Cap
2,433,349,026
Shares Outstanding
57,680,000
Weighted SO
57,678,122
Total Employees
N/A
Upcoming Earnings
11/07/2024
Beta
2.1220
Last Div
0.0000
Range
13.72-42.67
Chg
0.7200
Avg Vol
969358
Mkt Cap
2433349026
Exch
NASDAQ
Country
US
Phone
510 474 0170
DCF Diff
39.5797
DCF
-9.7797
Div Yield
0.0000
P/S
7.6252
EV Multiple
13.4942
P/FV
4.6784
Div Yield %
0.0000
P/E
14.9012
PEG
0.3093
Payout
0.0000
Current Ratio
13.7314
Quick Ratio
13.7314
Cash Ratio
8.5536
DSO
1.5670
DIO
0.0001
Op Cycle
1.5671
DPO
392.9353
CCC
-391.3683
Gross Margin
0.9894
Op Margin
0.4771
Pretax Margin
0.5409
Net Margin
0.5326
Eff Tax Rate
-0.0140
ROA
0.2765
ROE
0.8547
ROCE
0.2657
NI/EBT
0.9846
EBT/EBIT
1.1338
EBIT/Rev
0.4771
Debt Ratio
0.0222
D/E
0.0252
LT Debt/Cap
0.0199
Total Debt/Cap
0.0245
Int Coverage
66.3062
CF/Debt
16.9989
Equity Multi
1.1354
Rec Turnover
232.9343
Pay Turnover
0.9289
Inv Turnover
999999.9999
FA Turnover
26.5226
Asset Turnover
0.5192
OCF/Share
3.7769
FCF/Share
3.7656
Cash/Share
9.1998
OCF/Sales
0.7256
FCF/OCF
0.9970
CF Coverage
16.9989
ST Coverage
87.3743
CapEx Coverage
334.1154
Div&CapEx Cov
334.1154
P/BV
4.6784
P/B
4.6784
P/S
7.6252
P/E
14.9012
P/FCF
10.5409
P/OCF
10.9376
P/CF
10.9376
PEG
0.3093
P/S
7.6252
EV Multiple
13.4942
P/FV
4.6784
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
8.00K Shares Bought (9.28 %)
78.23K Shares Sold (90.72%)
3 - 6 Months
878.59K Shares Bought (87.16 %)
129.42K Shares Sold (12.84%)
6 - 9 Months
71.00K Shares Bought (40.84 %)
102.85K Shares Sold (59.16%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 2.35M | ▲ 2.72M | ▲ 5.65M | ▲ 8.62M | ▼ 0.00 | ▲ 60.00M | ▼ 4.17M |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | ▲ 819.00K | ▼ 256.00K | ▲ 832.00K | ▼ 0.00 |
Gross Profit | 2.35M | ▲ 2.72M | ▲ 5.65M | ▲ 7.80M | ▼ -256.00K | ▲ 59.17M | ▼ 4.17M |
Gross Profit Ratio | 1.00 | 1.00 | 1.00 | ▼ 0.90 | ▼ 0.00 | ▲ 0.99 | ▲ 1.00 |
Research And Development Expenses | 14.25M | ▲ 15.91M | ▲ 19.49M | ▲ 38.37M | ▼ 29.88M | ▼ 28.90M | ▲ 33.52M |
General And Administrative Expenses | 3.52M | ▲ 4.11M | ▲ 4.99M | ▲ 7.26M | ▼ 6.63M | ▲ 8.05M | ▲ 9.44M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 3.52M | ▲ 4.11M | ▲ 4.99M | ▲ 7.26M | ▼ 6.63M | ▲ 8.05M | ▲ 9.44M |
Other Expenses | 0.00 | ▲ 142.00K | ▼ -9.00K | ▼ -13.00K | ▲ 71.00K | ▼ 44.00K | ▼ 0.00 |
Operating Expenses | 17.77M | ▲ 20.02M | ▲ 24.48M | ▲ 45.63M | ▼ 36.52M | ▲ 36.95M | ▲ 42.96M |
Cost And Expenses | 17.77M | ▲ 20.02M | ▲ 24.48M | ▲ 45.63M | ▼ 36.52M | ▲ 36.95M | ▲ 42.96M |
Interest Income | 748.00K | ▼ 679.00K | ▼ 80.00K | ▲ 122.00K | ▲ 2.25M | ▲ 4.24M | ▲ 7.40M |
Interest Expense | 0.00 | ▲ 167.00K | ▼ 127.00K | ▼ 0.00 | ▼ -652.00K | ▲ 2.30M | ▼ 0.00 |
Depreciation And Amortization | 128.00K | ▲ 647.00K | ▼ 632.00K | ▲ 819.00K | ▼ 256.00K | ▲ 832.00K | ▼ 0.00 |
Ebitda | -15.41M | ▼ -16.48M | ▼ -18.76M | ▼ -36.91M | ▲ -36.52M | ▲ 23.88M | ▼ -38.79M |
Ebitda Ratio | -6.55 | ▲ -6.06 | ▲ -3.32 | ▼ -4.28 | ▲ 0.00 | ▲ 0.40 | ▼ -9.31 |
Operating Income | -15.41M | ▼ -17.30M | ▼ -18.83M | ▼ -37.02M | ▲ -36.52M | ▲ 23.05M | ▼ -38.79M |
Operating Income Ratio | -6.55 | ▲ -6.36 | ▲ -3.33 | ▼ -4.30 | ▲ 0.00 | ▲ 0.38 | ▼ -9.31 |
Total Other Income Expenses Net | 748.00K | ▼ 142.00K | ▼ -9.00K | ▼ -13.00K | ▲ 2.32M | ▼ 44.00K | ▲ 7.50M |
Income Before Tax | -14.66M | ▼ -16.65M | ▼ -18.89M | ▼ -36.91M | ▲ -34.19M | ▲ 27.34M | ▼ -31.29M |
Income Before Tax Ratio | -6.23 | ▲ -6.12 | ▲ -3.34 | ▼ -4.28 | ▲ 0.00 | ▲ 0.46 | ▼ -7.51 |
Income Tax Expense | -799.00K | ▲ 856.00K | ▼ -1.31M | ▲ -832.00K | ▼ -2.91M | ▼ -4.24M | ▲ 676.00K |
Net Income | -13.87M | ▼ -17.50M | ▼ -18.89M | ▼ -36.91M | ▲ -31.29M | ▲ 27.34M | ▼ -30.62M |
Net Income Ratio | -5.89 | ▼ -6.44 | ▲ -3.34 | ▼ -4.28 | ▲ 0.00 | ▲ 0.46 | ▼ -7.35 |
Eps | -0.57 | ▼ -0.63 | ▲ -0.48 | ▼ -0.77 | ▲ -0.64 | ▲ 0.45 | ▼ -0.50 |
Eps Diluted | -0.57 | ▼ -0.63 | ▲ -0.48 | ▼ -0.77 | ▲ -0.64 | ▲ 0.44 | ▼ -0.50 |
Weighted Average Shs Out | 24.19M | ▲ 27.61M | ▲ 39.61M | ▲ 48.15M | ▲ 49.26M | ▲ 60.39M | ▲ 61.31M |
Weighted Average Shs Out Dil | 24.19M | ▲ 27.61M | ▲ 39.61M | ▲ 48.15M | ▲ 49.26M | ▲ 61.80M | ▼ 61.31M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 82.23M | ▼ 33.01M | ▲ 117.36M | ▲ 123.67M | ▲ 125.74M | ▲ 186.73M | ▲ 355.64M |
Short Term Investments | 46.62M | ▲ 100.01M | ▲ 188.45M | ▲ 203.24M | ▼ 111.61M | ▲ 154.89M | ▲ 208.35M |
Cash And Short Term Investments | 128.85M | ▲ 133.02M | ▲ 307.81M | ▲ 326.90M | ▼ 237.36M | ▲ 341.62M | ▲ 564.00M |
Net Receivables | 6.02M | ▲ 6.76M | ▼ 3.51M | ▲ 4.36M | ▼ 52.00K | ▲ 10.33M | ▼ 0.00 |
Inventory | 2.14M | ▲ 4.80M | ▼ 3.98M | ▲ 8.50M | ▼ -94.00K | ▲ 0.00 | 0.00 |
Other Current Assets | 495.00K | ▲ 744.00K | ▼ 311.00K | ▲ 975.00K | ▼ 42.00K | ▲ 3.63M | ▲ 6.93M |
Total Current Assets | 137.50M | ▲ 145.31M | ▲ 315.61M | ▲ 340.74M | ▼ 237.36M | ▲ 355.58M | ▲ 570.93M |
Property Plant Equipment Net | 861.00K | ▲ 7.72M | ▼ 6.41M | ▲ 6.73M | ▼ 4.63M | ▼ 2.15M | ▲ 12.03M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -446.00K | ▲ 0.00 |
Long Term Investments | 0.00 | 0.00 | ▲ 2.00M | ▼ 225.00K | 225.00K | 225.00K | ▼ 0.00 |
Tax Assets | 658.00K | ▲ 1.43M | ▼ 0.00 | 0.00 | 0.00 | ▲ 221.00K | ▼ 0.00 |
Other Non Current Assets | 450.00K | 450.00K | 450.00K | ▼ 0.00 | ▲ 5.72M | ▼ 225.00K | ▲ 31.67M |
Total Non Current Assets | 1.97M | ▲ 9.61M | ▼ 8.86M | ▼ 6.96M | ▲ 10.57M | ▼ 2.37M | ▲ 43.70M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 139.47M | ▲ 154.92M | ▲ 324.47M | ▲ 347.70M | ▼ 247.93M | ▲ 357.95M | ▲ 614.63M |
Account Payables | 5.71M | ▼ 2.79M | ▲ 3.08M | ▼ 1.60M | ▲ 3.64M | ▼ 772.00K | ▲ 3.63M |
Short Term Debt | 1.06M | ▲ 1.26M | ▲ 1.46M | ▲ 2.20M | ▲ 2.52M | ▼ 1.14M | ▲ 2.65M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 2.65M |
Deferred Revenue | 8.22M | ▲ 41.53M | ▼ 14.48M | ▼ 1.60M | ▼ 69.00K | ▼ 3.00K | ▲ 20.12M |
Other Current Liabilities | 11.16M | ▼ -10.17M | ▲ 21.23M | ▲ 38.62M | ▼ 24.96M | ▼ 19.36M | ▼ 17.83M |
Total Current Liabilities | 26.16M | ▲ 35.41M | ▲ 40.24M | ▲ 44.02M | ▼ 31.18M | ▼ 21.27M | ▲ 41.58M |
Long Term Debt | 0.00 | ▲ 15.76M | ▼ 4.50M | ▼ 3.66M | ▼ 1.14M | ▼ 0.00 | ▲ 10.97M |
Deferred Revenue Non Current | 0.00 | ▲ 23.79M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | ▲ 20.76M |
Deferred Tax Liabilities Non Current | 658.00K | ▼ -5.96M | ▲ 0.00 | 0.00 | 0.00 | ▲ 221.00K | ▼ 0.00 |
Other Non Current Liabilities | 141.00K | ▲ 5.96M | ▼ 121.00K | ▼ 0.00 | ▲ 783.54M | ▼ 0.00 | 0.00 |
Total Non Current Liabilities | 799.00K | ▲ 39.55M | ▼ 4.62M | ▼ 3.66M | ▲ 784.68M | ▼ 221.00K | ▲ 31.73M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -31.18M | ▲ -221.00K | ▲ 0.00 |
Capital Lease Obligations | 0.00 | ▲ 7.22M | ▼ 5.96M | ▼ 5.86M | ▼ 3.66M | ▼ 1.14M | ▲ 10.97M |
Total Liabilities | 26.96M | ▲ 74.95M | ▼ 44.86M | ▲ 47.67M | ▲ 784.68M | ▼ 21.27M | ▲ 73.31M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00K | 1.00K |
Retained Earnings | -140.47M | ▼ -217.66M | ▼ -283.81M | ▼ -409.36M | ▼ -536.76M | ▼ -615.71M | ▲ -438.99M |
Accumulated Other Comprehensive Income Loss | -233.00K | ▲ -221.00K | ▲ 28.00K | ▼ -299.00K | ▼ -359.00K | ▲ -105.00K | ▼ -249.00K |
Other Total Stockholders Equity | 233.00K | ▼ 221.00K | ▼ -28.00K | ▲ 299.00K | ▲ 359.00K | ▲ 952.49M | ▲ 980.56M |
Total Stockholders Equity | -140.47M | ▼ -217.66M | ▼ -283.81M | ▼ -409.36M | ▼ -536.76M | ▲ 336.68M | ▲ 541.32M |
Total Equity | -140.47M | ▼ -217.66M | ▼ -283.81M | ▼ -409.36M | ▼ -536.76M | ▲ 336.68M | ▲ 541.32M |
Total Liabilities And Stockholders Equity | -113.52M | ▼ -142.71M | ▼ -238.95M | ▼ -361.69M | ▲ 247.93M | ▲ 357.95M | ▲ 614.63M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | -113.52M | ▼ -142.71M | ▼ -238.95M | ▼ -361.69M | ▲ 247.93M | ▲ 357.95M | ▲ 614.63M |
Total Investments | 46.62M | ▲ 100.01M | ▲ 190.45M | ▲ 203.24M | ▼ 111.61M | ▲ 154.89M | ▲ 208.35M |
Total Debt | 0.00 | ▲ 17.01M | ▼ 5.96M | ▼ 5.86M | ▼ 3.66M | ▼ 1.14M | ▲ 10.97M |
Net Debt | -82.23M | ▲ -16.00M | ▼ -111.40M | ▼ -117.81M | ▼ -122.09M | ▼ -185.59M | ▼ -344.67M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -13.87M | ▼ -17.50M | ▼ -18.89M | ▼ -36.91M | ▲ -34.19M | ▲ 27.34M | ▲ 207.34M |
Depreciation And Amortization | 128.00K | ▲ 647.00K | ▼ 632.00K | ▲ 819.00K | ▲ 840.00K | ▼ 832.00K | ▼ 820.00K |
Deferred Income Tax | -658.00K | ▲ 773.00K | ▼ 34.00K | ▼ 0.00 | 0.00 | ▲ 6.80M | ▼ 0.00 |
Stock Based Compensation | 2.07M | ▲ 2.16M | ▼ 1.97M | ▲ 5.02M | ▲ 5.51M | ▲ 6.60M | ▲ 9.35M |
Change In Working Capital | 2.29M | ▼ -208.00K | ▼ -2.94M | ▲ 3.62M | ▼ -2.88M | ▼ -16.46M | ▼ -243.33M |
Accounts Receivables | -1.00K | ▼ -4.81M | ▲ 363.00K | ▼ 151.00K | ▼ 82.00K | ▼ -10.00M | ▼ -290.04M |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -82.00K | ▲ 10.00M | ▼ 0.00 |
Accounts Payables | 813.00K | ▲ 1.17M | ▼ 277.00K | ▲ 895.00K | ▼ -1.08M | ▲ -597.00K | ▲ 2.83M |
Other Working Capital | 1.47M | ▼ -1.37M | ▼ -3.22M | ▲ 2.72M | ▼ -1.80M | ▼ -15.86M | ▲ 43.89M |
Other Non Cash Items | -98.00K | ▼ -160.00K | ▲ 329.00K | ▲ 509.00K | ▼ -914.00K | ▼ -1.35M | ▲ 296.60M |
Net Cash Provided By Operating Activities | -10.14M | ▼ -14.29M | ▼ -18.87M | ▼ -26.94M | ▼ -31.64M | ▲ 16.96M | ▼ -27.43M |
Investments In Property Plant And Equipment | -62.00K | ▼ -218.00K | ▲ -125.00K | ▼ -196.00K | ▲ -70.00K | ▲ -19.00K | ▼ -242.00K |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -4.01M | ▲ 61.27M | ▼ 0.00 |
Purchases Of Investments | -19.11M | ▼ -49.13M | ▼ -132.43M | ▲ -30.69M | ▼ -80.60M | ▼ -97.97M | ▲ -65.67M |
Sales Maturities Of Investments | 23.72M | ▲ 36.79M | ▲ 58.15M | ▲ 58.75M | ▲ 84.60M | ▼ 36.70M | ▲ 71.98M |
Other Investing Activities | 4.61M | ▼ -12.34M | ▼ -74.28M | ▲ 28.06M | ▼ 4.01M | ▼ -61.27M | ▲ 6.31M |
Net Cash Used For Investing Activities | 4.55M | ▼ -12.55M | ▼ -74.40M | ▲ 27.87M | ▼ 3.94M | ▼ -61.29M | ▲ 6.07M |
Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Issued | 477.00K | ▼ -22.17M | ▲ 126.67M | ▼ 2.17M | ▼ 553.00K | ▼ 527.00K | ▲ 7.80M |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 769.00K | ▼ -600.00K |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 2.00K | ▲ 31.95M | ▼ 313.00K | ▲ 2.17M | ▼ 553.00K | ▼ 527.00K | ▼ -600.00K |
Net Cash Used Provided By Financing Activities | 479.00K | ▲ 9.78M | ▲ 126.98M | ▼ 2.17M | ▼ 553.00K | ▼ 527.00K | ▲ 7.20M |
Effect Of Forex Changes On Cash | -87.00K | ▼ -125.00K | ▲ 21.00K | ▲ 22.00K | ▲ 75.00K | ▼ 0.00 | 0.00 |
Net Change In Cash | -5.19M | ▼ -17.19M | ▲ 33.73M | ▼ 3.12M | ▼ -27.07M | ▼ -43.80M | ▲ -14.16M |
Cash At End Of Period | 82.69M | ▼ 33.47M | ▲ 117.82M | ▲ 123.89M | ▲ 125.97M | ▲ 186.95M | ▼ 172.57M |
Cash At Beginning Of Period | 87.89M | ▼ 50.66M | ▲ 84.09M | ▲ 120.77M | ▲ 153.04M | ▲ 230.75M | ▼ 186.73M |
Operating Cash Flow | -10.14M | ▼ -14.29M | ▼ -18.87M | ▼ -26.94M | ▼ -31.64M | ▲ 16.96M | ▼ -27.43M |
Capital Expenditure | -62.00K | ▼ -218.00K | ▲ -125.00K | ▼ -196.00K | ▲ -70.00K | ▲ -19.00K | ▼ -242.00K |
Free Cash Flow | -10.20M | ▼ -14.51M | ▼ -18.99M | ▼ -27.14M | ▼ -31.71M | ▲ 16.94M | ▼ -27.67M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)